o.novak
Submits third-party assay reports on material purchased directly. Based in Konya.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
98.22%
n=9
Suppliers covered
7
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043335 | Liraglutide | CPC | CPC-2602-G1978 | Janoshik | 2026-Q3 | 97.29 | 4.91 | — | Laboratory-retained | 1 | FAIL |
| AX-2026-043526 | MK-677 (Ibutamoren mesylate) | BCH | BCH-2511-G7276 | Medutest | 2026-Q2 | 97.60 | 4.50 | — | Buyer-sourced | 1 | FAIL |
| AX-2026-042160 | GHRP-2 | Homopeptide | HOMO-2602-E9033 | Medutest | 2026-Q2 | 99.62 | 4.50 | 99.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043532 | MK-677 (Ibutamoren mesylate) | BCH | BCH-2511-G7276 | Janoshik | 2026-Q2 | 98.18 | 4.32 | — | Laboratory-retained | 1 | FAIL |
| AX-2026-043479 | BPC-157 | WXT | WXT-2602-P5658 | VendorInvestigate | 2026-Q1 | 98.22 | 1.12 | — | Buyer-sourced | 2 | MARGINAL |
| AX-2025-020373 | Retatrutide | MKM | MKM-2504-F3495 | Janoshik | 2025-Q2 | 98.59 | 7.12 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018718 | Tirzepatide | QSC | QSC-2408-T6517 | Medutest | 2025-Q1 | 99.40 | 5.70 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2024-005482 | Tirzepatide | BCH | BCH-2407-F6722 | VendorInvestigate | 2024-Q4 | 96.91 | 4.69 | — | Laboratory-retained | 2 | FAIL |
| AX-2024-004291 | Melanotan II | QYB | QYB-2402-P5428 | Janoshik | 2024-Q2 | 99.93 | 6.14 | 91.5 | Supplier-supplied | 1 | MARGINAL |